Direct anti-coagulant
Showing 1 - 25 of >10,000
Heart Failure Trial in Falls Church (Apixaban, Warfarin, LVAD implant)
Recruiting
- Heart Failure
- Apixaban
- +2 more
-
Falls Church, VirginiaInova Fairfax Medical Campus
Feb 21, 2022
Hepatitis C Trial (Zinc Supplement)
Not yet recruiting
- Hepatitis C
- Zinc Supplement
- (no location specified)
Jul 16, 2022
Coronary Artery Disease Trial in Jacksonville (Ticagrelor 60mg, Clopidogrel)
Recruiting
- Coronary Artery Disease
- Ticagrelor 60mg
- Clopidogrel
-
Jacksonville, FloridaUniversity of Florida
Jul 6, 2022
Migraine Trial in Talavera De La Reina (Transcranial direct current stimulation (tDCS), anti-CGRP-mAbs)
Completed
- Migraine
- Transcranial direct current stimulation (tDCS)
- anti-CGRP-mAbs
-
Talavera De La Reina, Toledo, SpainClinica de Intervencion en Neurociencias
Oct 15, 2023
Deep-Venous Thrombosis Trial in Leiden (IPD Device delivered by Converis, Fraxiparine)
Recruiting
- Deep-Venous Thrombosis
- IPD Device delivered by Converis
- Fraxiparine
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Centre
Apr 6, 2022
Hemophilia A or B With Inhibitors Trial in Zagreb, Skopje, Poltava (FEIBA)
Completed
- Hemophilia A or B With Inhibitors
- FEIBA
-
Zagreb, Croatia
- +2 more
Jan 20, 2022
Investigate if Early Atrial Fibrillation Diagnosis Reduces Risk
Recruiting
- Atrial Fibrillation
- Heart healthy Engagement Program with the Apple Watch Series 5 or later
- Anti-Coagulation Adherence Module with the Apple Watch Series 5 or later
-
San Mateo, CaliforniaEvidation Health
Mar 4, 2022
Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)
Not yet recruiting
- Liver Cancer
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2023
Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
-
Alton, Illinois
- +6 more
May 18, 2022
End Stage Renal Disease Trial in Washington (Drotrecogin alfa activated (Xigris))
Completed
- End Stage Renal Disease
- Drotrecogin alfa activated (Xigris)
-
Washington, District of ColumbiaThe George Washington University Hospital
Jan 6, 2022
COVID -19 Trial in Puducherry (Oral Antibiotic, Antihistamine, Anti-inflammatory, Multivitamins, Oral low dose steroid,
Completed
- COVID -19
- Oral Antibiotic, Antihistamine, Anti-inflammatory, Multivitamins
- +3 more
-
Puducherry, IndiaONLINE
Jun 22, 2021
Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small
Recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +4 more
- Daratumumab
- Ibrutinib
-
Jacksonville, FloridaMayo Clinic in Florida
Mar 22, 2022
Atrial Fibrillation Trial in Pessac (Specialized nurse consultation)
Active, not recruiting
- Atrial Fibrillation
- Specialized nurse consultation
-
Pessac, FranceCHU de Bordeaux
Feb 9, 2022
Hepatitis C Trial in Be'er Sheva, Petah Tikva (Direct acting anti-viral agents)
Completed
- Hepatitis C
- Direct acting anti-viral agents
-
Be'er Sheva, Israel
- +1 more
Feb 17, 2021
HIV/AIDS Trial in Beira (FCC (Força à Comunidade e Crianças) program- direct beneficiary, FCC (Força à Comunidade e Crianças)
Completed
- HIV/AIDS
- FCC (Força à Comunidade e Crianças) program- direct beneficiary
- +6 more
-
Beira, Sofala, MozambiqueLessitala Consultoria e Servicos
Aug 11, 2021
Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in
Active, not recruiting
- Pleural Effusion
- Thoracic Effusion
- Novel Oral Anti-Coagulants
-
New Haven, ConnecticutYale New Haven Hospital
Oct 10, 2022
Outcomes in Hospitalised Patients Treated With Ondexxya
Not yet recruiting
- Hemorrhage
- Andexanet alfa
- (no location specified)
Jun 12, 2023
Tumors, Thrombosis, Coagulation Disorder Trial in Nice (Blood sample analysis)
Completed
- Neoplasms
- +2 more
- Blood sample analysis
-
Nice, FranceCentre Antoine Lacassagne
Dec 12, 2022
Chronic Hepatitis C Trial in Parma (blood drawing)
Completed
- Chronic Hepatitis C
- blood drawing
-
Parma, ItalyUnit of Infectious Diseases and Hepatology
Jul 20, 2021
COVID-19 Trial in Mansoura (Sofosbuvir 400 MG plus Daclatasvir 200mg)
Unknown status
- COVID-19
- Sofosbuvir 400 MG plus Daclatasvir 200mg
-
Mansoura, Dakahlyia, EgyptMansoura Faculty of Medicine
Feb 22, 2021
Ventricular Tachycardia, Premature Ventricular Contraction, Stroke Trial in India, United States (DOAC, Aspirin)
Completed
- Ventricular Tachycardia
- +2 more
-
Kansas City, Kansas
- +4 more
Aug 30, 2021
Direct Acting Anti-Viral's In Chronic HCV Patients
Completed
- Safety Issues
-
Faisalabad, Punjab, PakistanLiver Center Faisalabad
Dec 10, 2020
Pre-Eclampsia Trial in Bordeaux (Blood sample)
Not yet recruiting
- Pre-Eclampsia
- Blood sample
-
Bordeaux, FranceCHU Bordeaux
Dec 28, 2022